Pavlova Maryna, Balaiya Velmurugan, Flores Jocelyn C, Ferreyros Michael, Bush Katie, Hopkin Amy, Kogut Igor, Roop Dennis R, Bilousova Ganna
Department of Dermatology, Gates Institute, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
AVITA Medical, Valencia, CA, USA.
Bio Protoc. 2024 Jan 20;14(2):e4919. doi: 10.21769/BioProtoc.4919.
Human skin reconstruction on immune-deficient mice has become indispensable for in vivo studies performed in basic research and translational laboratories. Further advancements in making sustainable, prolonged skin equivalents to study new therapeutic interventions rely on reproducible models utilizing patient-derived cells and natural three-dimensional culture conditions mimicking the structure of living skin. Here, we present a novel step-by-step protocol for grafting human skin cells onto immunocompromised mice that requires low starting cell numbers, which is essential when primary patient cells are limited for modeling skin conditions. The core elements of our method are the sequential transplantation of fibroblasts followed by keratinocytes seeded into a fibrin-based hydrogel in a silicone chamber. We optimized the fibrin gel formulation, timing for gel polymerization in vivo, cell culture conditions, and seeding density to make a robust and efficient grafting protocol. Using this approach, we can successfully engraft as few as 1.0 × 10 fresh and 2.0 × 10 frozen-then-thawed keratinocytes per 1.4 cm of the wound area. Additionally, it was concluded that a successful layer-by-layer engraftment of skin cells in vivo could be obtained without labor-intensive and costly methodologies such as bioprinting or engineering complex skin equivalents. Key features • Expands upon the conventional skin chamber assay method (Wang et al., 2000) to generate high-quality skin grafts using a minimal number of cultured skin cells. • The proposed approach allows the use of frozen-then-thawed keratinocytes and fibroblasts in surgical procedures. • This system holds promise for evaluating the functionality of skin cells derived from induced pluripotent stem cells and replicating various skin phenotypes. • The entire process, from thawing skin cells to establishing the graft, requires 54 days. Graphical overview.
在免疫缺陷小鼠上进行人皮肤重建,对于基础研究和转化实验室开展的体内研究而言已变得不可或缺。为了研究新的治疗干预措施而制备可持续、长期存活的皮肤等效物,其进一步发展依赖于利用患者来源的细胞以及模拟活皮肤结构的天然三维培养条件的可重复模型。在此,我们提出了一种新颖的逐步方案,用于将人皮肤细胞移植到免疫受损小鼠身上,该方案所需的起始细胞数量较少,这在用于模拟皮肤状况的原代患者细胞有限时至关重要。我们方法的核心要素是先依次移植成纤维细胞,然后将角质形成细胞接种到硅树脂腔室中的纤维蛋白基水凝胶中。我们优化了纤维蛋白凝胶配方、体内凝胶聚合时间、细胞培养条件和接种密度,以制定一个稳健且高效的移植方案。使用这种方法,每1.4平方厘米伤口面积,我们能够成功移植低至1.0×10个新鲜的以及2.0×10个冻融后的角质形成细胞。此外,得出的结论是,无需生物打印或构建复杂的皮肤等效物等劳动密集型且成本高昂的方法,就可以在体内成功实现皮肤细胞的逐层移植。关键特性 • 在传统皮肤腔室检测方法(Wang等人,2000年)的基础上进行扩展,使用最少数量的培养皮肤细胞生成高质量的皮肤移植物。 • 所提出的方法允许在手术过程中使用冻融后的角质形成细胞和成纤维细胞。 • 该系统有望评估诱导多能干细胞来源的皮肤细胞的功能,并复制各种皮肤表型。 • 从解冻皮肤细胞到建立移植物的整个过程需要54天。图形概述。